CSF2 and COVID-19: We observed significantly increased levels of inflammatory cytokines/chemokines such as GM-CSF, IL-15, IL-6 and IL-8 in both SOT and Non-SOT COVID-19 patients who subsquently developed severe disease compared to patients with mild/moderate disease.